目次
1. グローバルな電気医療＆電気治療器市場 エグゼクティブサマリー
1.1. グローバル市場規模および予測（2022年～2032年）
1.2. 地域別概要
1.3. セグメント別概要
1.3.1. 製品別
1.3.2. 用途別
1.3.3. エンドユース別
1.4. 主要トレンド
1.5. 不況の影響
1.6. アナリストの推奨事項および結論
2. 世界市場の定義および調査の前提条件
2.1. 調査目的
2.2. 市場の定義
2.3. 調査の前提条件
2.3.1. 対象範囲および対象外
2.3.2. 制限事項
2.3.3. 供給サイド分析
2.3.3.1. 材料の入手可能性
2.3.3.2. サプライチェーンに影響を与える規制枠組み
2.3.3.3. 製造インフラ
2.3.3.4. 技術的進歩
2.3.4. 需要側分析
2.3.4.1. 進化する消費者嗜好
2.3.4.2. 地域医療の傾向
2.3.4.3. 需要における技術統合
2.3.4.4. 価格と手頃さの力学
2.4. 推定方法
2.5. 調査対象年
3. 世界の電気医療および電気治療機器市場の力学
3.1. 市場の推進要因
3.1.1. 慢性疾患の増加
3.1.2. 医療機器の技術的進歩
3.1.3. 在宅医療ソリューションに対する需要の高まり
3.1.4. 世界的な高齢化人口の影響
3.2. 市場の課題
3.2.1. 地域を横断した厳しい規制要件
3.2.2. 先進機器の高コスト
3.2.3. 新興市場における認知度の低さ
3.3. 市場の機会
3.3.1. 新興経済圏への拡大
3.3.2. 人工知能と遠隔モニタリングソリューションの統合
3.3.3. 医療インフラへの政府投資の増加
4. 世界の電気医療および電気治療機器業界分析
4.1. ポーターのファイブフォースモデル
4.1.1. 供給業者の交渉力
4.1.2. 購入者の交渉力
4.1.3. 新規参入の脅威
4.1.4. 代替品の脅威
4.1.5. 競争上の競合の激しさ
4.2. PESTEL分析
4.2.1. 政治環境
4.2.2. 経済的要因
4.2.3. 社会動態
4.2.4. 技術革新
4.2.5. 環境への配慮
4.2.6. 法的規制
5. 世界の電気医療および電気治療用器具の市場規模および予測（2022年～2032年）製品別
5.1. 市場概要
5.2. 診断用機器
5.2.1. MRIシステム
5.2.2. CTスキャナー
5.2.3. ECGモニター
5.3. 治療用機器
5.3.1. 神経調節システム
5.3.2. 電気療法ユニット
5.3.3. インスリンポンプ
6. 用途別世界の電気医療および電気治療用器具の市場規模および予測（2022年～2032年）
6.1. 市場概要
6.2. 循環器科
6.3. 神経科
6.4. 腫瘍内科
6.5. その他の用途
7. 世界の電気医療および電気治療用器具市場規模および予測（2022年～2032年）エンドユース別
7.1. 市場概要
7.2. 病院
7.3. 診断センター
7.4. 在宅医療
7.5. その他のエンドユース
8. 世界の電気医療および電気治療用器具市場規模および予測（2022年～2032年）地域別
8.1. 北米
8.1.1. 米国
8.1.2. カナダ
8.2. ヨーロッパ
8.2.1. 英国
8.2.2. ドイツ
8.2.3. フランス
8.2.4. スペイン
8.2.5. イタリア
8.2.6. ヨーロッパのその他地域
8.3. アジア太平洋
8.3.1. 中国
8.3.2. インド
8.3.3. 日本
8.3.4. オーストラリア
8.3.5. 韓国
8.3.6. アジア太平洋地域その他
8.4. ラテンアメリカ
8.4.1. ブラジル
8.4.2. メキシコ
8.4.3. ラテンアメリカその他
8.5. 中東およびアフリカ
8.5.1. サウジアラビア
8.5.2. アラブ首長国連邦
8.5.3. 南アフリカ
8.5.4. 中東およびアフリカのその他地域
9. 競合情報
9.1. SWOT分析（上位3社
9.1.1. Medtronic
9.1.2. GE HealthCare
9.1.3. Siemens Healthineers AG
9.2. 主要企業の主要戦略
9.3. 企業プロフィール
Medtronic
GE HealthCare
Siemens Healthineers AG
Koninklijke Philips N.V.
Fujifilm Holdings Corporation
Boston Scientific Corporation
Abbott
Zimmer Biomet
Nihon Kohden Corporation
OMRON Healthcare, Inc.
Invacare Corporation
AliveCor, Inc.
iRhythm Technologies, Inc.
Magnus Medical, Inc.
Asensus Surgical, Inc.
10. 調査プロセス
10.1. 調査プロセス概要
10.2. データ収集の処置
10.2.1. 一次調査
10.2.2. 二次調査
10.3. データ検証の処置
10.3.1. 三角測量法
10.3.2. 専門家インタビュー
10.4. 市場推定のアプローチ
10.4.1. ボトムアップ推定
10.4.2. トップダウン推定
10.5. 制限および想定
10.5.1. 範囲の制限
10.5.2. 市場の動的な変化
Major factors contributing to the industry growth include the increasing prevalence of chronic conditions such as cancer, diabetes, and cardiovascular diseases (CVDs), technological advancements, rising public awareness of treatment and diagnostic options, and a growing elderly population. According to the World Health Organization (WHO), by 2030, one in six people globally will be aged 60 or older. The number of individuals aged 60 and above is expected to rise from 1 billion in 2020 to 1.4 billion, and this figure is projected to double to 2.1 billion by 2050.
The electro-medical and electrotherapeutic apparatus industry encompasses a diverse range of devices used for medical purposes, including diagnostic imaging, patient monitoring, and therapeutic treatments. These devices are designed to deliver high precision and reliability, meeting the specific needs of healthcare providers. The growing prevalence of chronic disorders, such as cancer, diabetes, cardiovascular diseases, and respiratory illnesses, is a key factor driving demand. For instance, cardiovascular diseases are the leading cause of death worldwide, responsible for approximately 17.9 million deaths annually, according to the WHO. The increasing burden of chronic conditions requiring continuous monitoring and advanced diagnostic tools underscores the necessity of these devices, bolstering market growth.
Technological advancements in the industry, such as artificial intelligence, machine learning, and remote patient monitoring, are further enhancing the capabilities of electro-medical devices. These innovations not only improve the accuracy of diagnoses and the efficacy of treatments but also make healthcare services more accessible and affordable. For example, home-use devices like blood glucose monitors and insulin pumps enable patients to manage their health independently, reducing the frequency of hospital visits. By facilitating personalized care and remote monitoring, these advancements are contributing to improved patient outcomes and further adoption of these devices.
The market is also witnessing robust growth due to strategic initiatives by industry players. Companies are focusing on introducing innovative products and securing regulatory approvals to strengthen their market position. For instance, Fujifilm Holdings Corporation launched the APERTO Lucent MRI system in the U.S. in July 2024, a high-performance open MRI designed to enhance imaging capabilities. Similarly, Zimmer Biomet obtained FDA clearance for its ROSA Shoulder System in February 2024, catering to the growing demand for robotic-assisted surgical tools.
The geographical landscape of the market highlights significant regional variations. North America held the largest market share in 2024, driven by advanced healthcare infrastructure, a high adoption rate of innovative technologies, and substantial research and development investments. Asia Pacific is projected to exhibit the fastest growth over the forecast period due to improving healthcare infrastructure, rising prevalence of chronic diseases, and an expanding elderly population. Countries such as China and Japan are leading this growth, supported by government initiatives and increased healthcare investments.
Major market players in this report include:
• Medtronic
• GE HealthCare
• Siemens Healthineers AG
• Koninklijke Philips N.V.
• Fujifilm Holdings Corporation
• Boston Scientific Corporation
• Abbott
• Zimmer Biomet
• Nihon Kohden Corporation
• OMRON Healthcare, Inc.
• Invacare Corporation
• AliveCor, Inc.
• iRhythm Technologies, Inc.
• Magnus Medical, Inc.
• Asensus Surgical, Inc.
The detailed segments and sub-segments of the market are explained below:
By Product:
• Diagnostic Equipment
• Therapeutic Equipment
By Application:
• Cardiology
• Neurology
• Oncology
• Others
By End Use:
• Hospitals
• Diagnostic Centers
• Homecare Settings
By Region: North America:
• U.S.
• Canada
Europe:
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific:
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
Latin America:
• Brazil
• Mexico
Middle East & Africa:
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Years considered for the study are as follows:
• Historical year: 2022
• Base year: 2023
• Forecast period: 2024 to 2032
Key Takeaways:
• Market estimates and forecasts for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of geographical landscapes with country-level insights for major regions.
• Competitive landscape, including information on major players.
• Insights into key business strategies and recommendations for future market approaches.
• Analysis of the competitive structure of the market.
• Demand-side and supply-side market analysis.
Table of Content
1. Global Electro-medical and Electrotherapeutic Apparatus Market Executive Summary
1.1. Global Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Application
1.3.3. By End Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendations & Conclusions
2. Global Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply-Side Analysis
2.3.3.1. Availability of Materials
2.3.3.2. Regulatory Frameworks Impacting the Supply Chain
2.3.3.3. Manufacturing Infrastructure
2.3.3.4. Technological Advancements
2.3.4. Demand-Side Analysis
2.3.4.1. Evolving Consumer Preferences
2.3.4.2. Regional Healthcare Trends
2.3.4.3. Technological Integration in Demand
2.3.4.4. Pricing and Affordability Dynamics
2.4. Estimation Methodology
2.5. Years Considered for the Study
3. Global Electro-medical and Electrotherapeutic Apparatus Market Dynamics
3.1. Market Drivers
3.1.1. Rising Prevalence of Chronic Diseases
3.1.2. Technological Advancements in Medical Devices
3.1.3. Increasing Demand for Home-based Healthcare Solutions
3.1.4. Global Aging Population Impact
3.2. Market Challenges
3.2.1. Stringent Regulatory Requirements Across Regions
3.2.2. High Costs of Advanced Equipment
3.2.3. Limited Awareness in Emerging Markets
3.3. Market Opportunities
3.3.1. Expansion into Emerging Economies
3.3.2. Integration of Artificial Intelligence and Remote Monitoring Solutions
3.3.3. Increased Government Investments in Healthcare Infrastructure
4. Global Electro-medical and Electrotherapeutic Apparatus Industry Analysis
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Intensity of Competitive Rivalry
4.2. PESTEL Analysis
4.2.1. Political Environment
4.2.2. Economic Factors
4.2.3. Social Dynamics
4.2.4. Technological Innovations
4.2.5. Environmental Considerations
4.2.6. Legal Regulations
5. Global Electro-medical and Electrotherapeutic Apparatus Market Size & Forecast by Product (2022–2032)
5.1. Market Overview
5.2. Diagnostic Equipment
5.2.1. MRI Systems
5.2.2. CT Scanners
5.2.3. ECG Monitors
5.3. Therapeutic Equipment
5.3.1. Neuromodulation Systems
5.3.2. Electrotherapy Units
5.3.3. Insulin Pumps
6. Global Electro-medical and Electrotherapeutic Apparatus Market Size & Forecast by Application (2022–2032)
6.1. Market Overview
6.2. Cardiology
6.3. Neurology
6.4. Oncology
6.5. Other Applications
7. Global Electro-medical and Electrotherapeutic Apparatus Market Size & Forecast by End Use (2022–2032)
7.1. Market Overview
7.2. Hospitals
7.3. Diagnostic Centers
7.4. Homecare Settings
7.5. Other End Uses
8. Global Electro-medical and Electrotherapeutic Apparatus Market Size & Forecast by Region (2022–2032)
8.1. North America
8.1.1. U.S.
8.1.2. Canada
8.2. Europe
8.2.1. U.K.
8.2.2. Germany
8.2.3. France
8.2.4. Spain
8.2.5. Italy
8.2.6. Rest of Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. Australia
8.3.5. South Korea
8.3.6. Rest of Asia Pacific
8.4. Latin America
8.4.1. Brazil
8.4.2. Mexico
8.4.3. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. South Africa
8.5.4. Rest of Middle East & Africa
9. Competitive Intelligence
9.1. SWOT Analysis (Top 3 Companies)
9.1.1. Medtronic
9.1.2. GE HealthCare
9.1.3. Siemens Healthineers AG
9.2. Key Strategies of Major Players
9.3. Company Profiles
9.3.1. Medtronic
9.3.2. GE Healthcare
9.3.3. Siemens Healthineers AG
9.3.4. Koninklijke Philips N.V.
9.3.5. Boston Scientific Corporation
9.3.6. Nihon Kohden Corporation
9.3.7. Zimmer Biomet
10. Research Process
10.1. Research Process Overview
10.2. Data Collection Techniques
10.2.1. Primary Research
10.2.2. Secondary Research
10.3. Data Validation Techniques
10.3.1. Triangulation Method
10.3.2. Expert Interviews
10.4. Market Estimation Approach
10.4.1. Bottom-up Estimation
10.4.2. Top-down Estimation
10.5. Limitations and Assumptions
10.5.1. Scope Constraints
10.5.2. Dynamic Market Changes
❖ 掲載企業 ❖
Medtronic、GE HealthCare、Siemens Healthineers AG、Koninklijke Philips N.V.、Fujifilm Holdings Corporation、Boston Scientific Corporation、Abbott、Zimmer Biomet、Nihon Kohden Corporation、OMRON Healthcare, Inc.、Invacare Corporation、AliveCor, Inc.、iRhythm Technologies, Inc.、Magnus Medical, Inc.、Asensus Surgical, Inc.など
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
